Taiko Pharmaceutical Co.,Ltd. provided earnings guidance for the year ending December 2023. For the year, the company's net sales to be ¥6,400 million, operating profit to be ¥(800)million, net income to be ¥(950) million or Basic earnings per share to be ¥(20.42).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
375 JPY | +0.27% | +0.54% | +23.76% |
1st Jan change | Capi. | |
---|---|---|
+23.76% | 121M | |
+18.09% | 41.07B | |
+24.16% | 22.65B | |
+15.71% | 15.02B | |
+20.11% | 14.14B | |
+52.15% | 12.09B | |
-10.97% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+15.28% | 5.59B |
- Stock Market
- Equities
- 4574 Stock
- News Taiko Pharmaceutical Co.,Ltd.
- Taiko Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Year Ending December 2023